To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice
The need for therapeutic drug monitoring of direct oral anticoagulants (DOACs) remains an area of clinical equipoise. Although routine monitoring may be unnecessary given predictable pharmacokinetics in most patients, there may be altered pharmacokinetics in those with end organ dysfunction, such as...
Saved in:
Main Authors: | Tania Ahuja, Veronica Raco, Sharonlin Bhardwaj, David Green |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2023/9511499 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01) -
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
by: Sherif Elhosseiny, et al.
Published: (2019-01-01) -
Direct oral anticoagulants for stroke prevention and risk of bleeding
by: Tomoyuki Kawada
Published: (2025-02-01) -
Predictors of direct oral anticoagulant concentrations in the trauma population
by: Laura Adams, et al.
Published: (2024-05-01) -
HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS
by: Armando Tripodi
Published: (2024-02-01)